Komori
T

Techno Medica Co.,Ltd.

6678Electric appliances and precision instrumentsMicro cap
2,037JPY+0.0%
★ Watch (sign-up required)
Price history
¥2,037Latest+27.3%
Drag across the chart to measure the move between two points.Delayed 15 minutes · monthly closing basis
Business overview

The Company’s principal business activities are the research and development, manufacture, sale and export of analyzers for clinical testing and medical equipment, the manufacture and sale of consumables used with these devices, and related activities including device maintenance services. Products are sold either directly to domestic and overseas users or through distributors. The Company has no subsidiaries or affiliated companies. Although the business comprises a single segment, products are classified into the following 3 categories: (1) blood collection tube preparation equipment and systems, including related systems and peripheral equipment; (2) specimen testing equipment, including blood gas analyzers and similar products; and (3) consumables and other products, including labels, standard serum and sensor cards, together with maintenance services. The principal products fall into these 3 categories. Research and development and design are performed in-house, while manufacturing is outsourced to external partner companies. Inspections and quality assurance are conducted in 2 stages before shipment. In the event of a defect, the same lot is recalled and replaced. The Company is also focusing on the development and sale of self-monitoring products.

Recurring subjects
No threads yetThis company's filings have not been read yet. We are adding them progressively.
Companies sharing a theme
Loading
Key numbersShowing 8 of 20
PER
112.94How many years of earnings it would take to buy the stock. The market average is generally considered to be around 15.
PBR
1.3How many times the company's net assets? Around 1x is generally considered a benchmark.
ROE
1.2%Earning power. A figure above 10% is generally considered good.
Dividend yield
0.0%The annual dividend as a percentage of the share price.
Market capitalization
¥18bnShare price × number of shares. The value of the entire company.
Equity ratio
84.4%The proportion of assets funded by money that does not have to be repaid.
Operating margin
10.7%The percentage of revenue remaining from the company’s core business.
Revenue growth (3 years)
7.5%The average annual growth in sales over the past three years.
What to watch next
Continued monitoring of installations and orders in Japan and overseas for blood collection tube preparation equipment and systems, particularly BC and ROBO-9000RFID/large-scale RFID systems
Next earnings announcement through the fiscal year ending March 2027Impact HighLikelihood Medium
Continued strength in sales of consumables and other products, and the effectiveness of coordination between price revisions and promotional activities in response to higher raw material costs, including the impact on margins
Next earnings announcement through the second half of fiscal 2026Impact HighLikelihood High
Accumulation of additional orders and continuing contracts for large overseas projects in Southeast Asia, China and other markets
Second half of fiscal 2026 through the fiscal year ending March 2027Impact MediumLikelihood Medium
Progress in self-monitoring-related products, including launch timing and whether sales are recognized
Timing unknown, subject to progress disclosuresImpact MediumLikelihood Low
Continued maintenance and operation of regulatory and QMS-related approvals, including whether any material corrective actions or renewal delays arise
As needed, in line with earnings briefings and renewal schedulesImpact HighLikelihood Low
What to watch next
Loading
Who owns itTop holders total 57.6%
Listed holders 57.6%Everyone else 42.4%
株式会社オートニクス14.50%
Saneichi Masatomo (実吉 政知)12.63%
The Master Trust Bank of Japan, Ltd. (Trust Account)6.63%
Nomura Trust and Banking Co., Ltd. (Investment Trust Account)5.69%
NORTHERN TRUST CO. (AVFC) RE FIDELITY FUNDS (standing proxy: The Hongkong and Shanghai Banking Corporation Limited, Tokyo Branch)5.45%
平澤 修3.67%
THE HONGKONG AND SHANGHAI BANKING CORPORATION LIMITED-HONG KONG PRIVATE BANKING DIVISION CLIENT A/C 8028-394841(常任代理人 香港上海銀行東京支店)3.29%
テクノメディカ従業員持株会2.29%
2 other listed holders3.42%
Who owns it
HolderOwnership (%)
株式会社オートニクス14.50
Saneichi Masatomo (実吉 政知)12.63
The Master Trust Bank of Japan, Ltd. (Trust Account)6.63
Nomura Trust and Banking Co., Ltd. (Investment Trust Account)5.69
NORTHERN TRUST CO. (AVFC) RE FIDELITY FUNDS (standing proxy: The Hongkong and Shanghai Banking Corporation Limited, Tokyo Branch)5.45
平澤 修3.67
THE HONGKONG AND SHANGHAI BANKING CORPORATION LIMITED-HONG KONG PRIVATE BANKING DIVISION CLIENT A/C 8028-394841(常任代理人 香港上海銀行東京支店)3.29
テクノメディカ従業員持株会2.29
2 other listed holders3.42
This company's documents
Timely disclosures
Threads